30
Fri, Oct
48 New Articles

“Things are, right now, Covid-driven again, really,” begins Partner Marc Lager, the head of the EU Competition Law and Global Trade practice in the Vienna office of Deloitte Legal. “The numbers have been going up a bit lately, as in other parts of Europe, and there have been talks of reintroducing some of the measures that were in place earlier in the year.”

Binder Groesswang, Schiff Hardin, and Hengeler Mueller have advised California-based medical devices and life science instruments manufacturer Paramit Corporation on the acquisition of 100% of shares in Austria's System Industrie Electronic GmbH and its German subsidiary, System Industrie Electronic Deutschland GmbH, from former majority shareholder System Industrie Holding AG (and its ultimate owner, the Filzmaier Private Foundation) and Aws Mittelstandsfonds, a former minority shareholder. Brandl & Talos advised the sellers on the transaction, which remains subject to regulatory clearance in both Austria and Germany.

Binder Groesswang and Willkie Farr & Gallagher have advised private equity investment company Ardian on the sale of Gantner Electronic Austria Holding GmbH to Salto Systems. Wolf Theiss and Spanish law firm Garrigues advised Salto Systems on the transaction.

Binder Groesswang has advised Lafayette Mittelstand Capital on its acquisition of the elevator cable business from the Gebauer & Griller Group as part of a carve-out. DLA Piper advised Gebauer & Griller on the deal, which closed in early October.

As of 11 October 2020 the EU FDI Screening Regulation is in force, ending the long wait for a Union framework to screen foreign direct investments. The umbrella spanned by the EU FDI Regulation is a further (crucial) building block in the EU's endeavors to tighten and coordinate the screening of foreign direct investments.

Eisenberger & Herzog, Milbank, and Rojs, Peljhan, Prelesnik & Partners have advised the Sartorius Group on its acquisition of BIA Separations and the merger of is into its subgroup Sartorius Stedim Biotech. Schoenherr advised the unidentified majority shareholder on the sale.

Our Latest Issue